Mediphage Bioceuticals is a non-viral gene therapy company focused on developing safe, effective and durable gene therapies for patients worldwide. Our flagship technology, ministring DNA, is a novel form of non-viral transgene delivery that achieves safety, redosability, and efficient and scalable manufacturing. Currently, Mediphage Bioceuticals is focusing its in-house efforts on applying ministring DNA as a therapeutic solution for Stargardt Disease and a COVID-19 DNA vaccine.